Please use this identifier to cite or link to this item:
https://repositorio.uca.edu.ar/handle/123456789/13671| Título : | Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 | Autor : | Reiter, Russel J. Cardinali, Daniel Pedro Neel, Richard L. Domínguez Rodriguez, Alberto Brown, Gregory M. Tesarik, Jan |
Palabras clave : | MELATONINA; SARS-CoV-19; VARIANTE DELTA COVID-19; VARIANTES FUTURAS | Fecha de publicación : | 2021 | Editorial : | ST-Bio-Life LLC | Cita : | Reiter, R.J. et al. Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2 [en línea]. Melatonin Research. 2021, 4 (3). doi: 10.32794/mr112500107. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/13671 | Resumen : | Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus. | URI : | https://repositorio.uca.edu.ar/handle/123456789/13671 | ISSN : | 2641-0281 (online) | Disciplina: | MEDICINA | DOI: | 10.32794/mr112500107 | Derechos: | Acceso abierto |
| Appears in Collections: | Artículos |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| rationale-continued-use-melatonin.pdf | 233,13 kB | Adobe PDF |  View/Open |
Page view(s)
63
checked on Apr 27, 2024
Download(s)
44
checked on Apr 27, 2024
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License
